Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional effects of Deoxynivalenol in primary monocyte-derived cells

ABSTRACT: Transcriptional effects of Deoxynivalenol in primary monocyte-derived cells

PROVIDER: PRJNA1051630 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptional effects of Deoxynivalenol in primary monocyte-derived cells

Project description:in vitro microarray study of transcriptional changes of primary monocyte-derived cells

2023-12-18 | GSE250031 | GEO

Transcriptional effects of Deoxynivalenol on intestinal porcine epithelial cells (IPEC-J2)

Project description:Transcriptional effects of Deoxynivalenol on intestinal porcine epithelial cells (IPEC-J2)

| PRJNA436125 | ENA

Deoxynivalenol affects the gene expression of A549 lung epithelial cells

Project description:Deoxynivalenol (DON) is an important Fusarium toxin of concern for food safety. The inhalation of powder contaminated with deoxynivalenol is possible and may cause lung toxicity. In this study, we investigated the gene expression profile of A549 cells treated with 0.2 microg/mL deoxynivalenol by microarray analysis. In total, 16 genes and 5 noncoding RNAs were significantly affected by deoxynivalenol treatment.

2016-02-29 | GSE60928 | GEO

Deoxynivalenol affects the gene expression of A549 lung epithelial cells

2016-02-29 | E-GEOD-60928 | biostudies-arrayexpress

Monocyte-derived Macrophages

Project description:Monocyte-derived Macrophages

| PRJNA948022 | ENA

Expression data from human primary monocyte derived immature dendritic cells (iDC)

Project description:Expression data from human primary monocyte derived immature dendritic cells (iDC)

| PRJNA903375 | ENA

cART Treated monocyte derived macrophages

Project description:primary human monocyte derived macrophages (MDMs) treated with antiretrovirals, specifically Atripla (A) or Triumeq (T)

2022-02-28 | GSE195708 | GEO

Proteomic analysis of monocyte-derived Extracellular vesicles

Project description:Extracellular vesicles (EV) convey biological messages through their cargoes. Herein we focus on monocyte/platelet aggregates characteristic of several cardiovascular diseases with an analysis of monocyte-derived EV (mEVs) effects on the atherosclerotic plaque. Monocyte preparations were stimulated with TNF-α in presence or absence of prostacyclin and EVs isolated via centrifugation. EV physical characteristics were determined by Nanoparticle Tracking analysis while surface profile was analysed using imaging flow cytometry. Atherosclerotic plaques from 5 patients undergoing endarterectomy were cultured with or without mEVs. Cytokines and proteins released in the culture media were measured by multiplex ELISA and mass spectrometry. Proteomic of mEVs prepared in different incubation settings was also conducted. Monocyte isolation yielded ~80% platelet-monocyte aggregates. TNF-α stimulation produced CD14+ EVs as well as a subset bearing the CD41 marker for platelets (CD14+/CD41+). Prostacyclin addition did not modulate monocyte/platelet aggregates, but impacted on mEV numbers. Addition of TNF-α mEVs on atherosclerotic plaque fragments impacted on general protein release (19 upregulated and 7 downregulated) and elevated cytokine release. mEVs generated by TNF-α and prostacyclin produced minimal changes on plaque reactivity. Proteomic analysis of mEVs revealed a distinctive composition when the cell preparation was activated with TNF-α alone or with prostacyclin. In conclusion, mEVs activate the atherosclerotic plaque. Attenuating platelet activation has an effect on EV composition with downstream modulation of their pro-inflammatory actions. EV heterogeneity reflects the mode of activation of the cell of origin and may differently contribute to the development and progression of atherosclerosis.

2021-09-08 | PXD014325 | Pride

Salmonella Typhimurium: control vs. Deoxynivalenol (DON) treatment

Project description:Transcriptional profiling of log and stationary phase S. Typhimurium, comparing untreated controls with Deoxynivalenol treated samples.

2011-05-20 | GSE29399 | GEO

Transcriptional effects of Deoxynivalenol on intestinal porcine epithelial cells (IPEC-J2) under low glucose condition

Project description:Transcriptional effects of Deoxynivalenol on intestinal porcine epithelial cells (IPEC-J2) under low glucose condition

| PRJNA436128 | ENA